Obsidian Therapeutics SEC filings: 8-K

Filter: All · 8-K · 10-Q · 10-K · Form 4

8-KAug. 3, 2026, 5:08 p.m. ETView on SEC.gov
Entry into a material definitive agreement · Completion of acquisition or disposition of assets · Results of operations and financial condition · Unregistered sales of equity securities · Material modification of security holders' rights · Change in certifying accountant · Change in control · Departure/appointment of directors or officers · Amendments to articles or bylaws; fiscal year change · Regulation FD disclosure · Financial statements and exhibits